ID   ALF_ECOLI               Reviewed;         359 AA.
AC   P0AB71; P11604; Q2M9R7;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   15-MAR-2017, entry version 102.
DE   RecName: Full=Fructose-bisphosphate aldolase class 2;
DE            Short=FBP aldolase;
DE            Short=FBPA;
DE            EC=4.1.2.13;
DE   AltName: Full=Fructose-1,6-bisphosphate aldolase;
DE   AltName: Full=Fructose-bisphosphate aldolase class II;
GN   Name=fbaA; Synonyms=fba, fda; OrderedLocusNames=b2925, JW2892;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12 / CS520;
RX   PubMed=2546007; DOI=10.1111/j.1365-2958.1989.tb00221.x;
RA   Alefounder P.R., Perham R.N.;
RT   "Identification, molecular cloning and sequence analysis of a gene
RT   cluster encoding the class II fructose 1,6-bisphosphate aldolase, 3-
RT   phosphoglycerate kinase and a putative second glyceraldehyde 3-
RT   phosphate dehydrogenase of Escherichia coli.";
RL   Mol. Microbiol. 3:723-732(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 2-27.
RX   PubMed=2649077; DOI=10.1042/bj2570529;
RA   Alefounder P.R., Baldwin S.A., Perham R.N., Short N.J.;
RT   "Cloning, sequence analysis and over-expression of the gene for the
RT   class II fructose 1,6-bisphosphate aldolase of Escherichia coli.";
RL   Biochem. J. 257:529-534(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-13.
RC   STRAIN=K12 / EMG2;
RX   PubMed=9298646; DOI=10.1002/elps.1150180807;
RA   Link A.J., Robison K., Church G.M.;
RT   "Comparing the predicted and observed properties of proteins encoded
RT   in the genome of Escherichia coli K-12.";
RL   Electrophoresis 18:1259-1313(1997).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-5.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9600841; DOI=10.1006/jmbi.1998.1726;
RA   Wilkins M.R., Gasteiger E., Tonella L., Ou K., Tyler M.,
RA   Sanchez J.-C., Gooley A.A., Walsh B.J., Bairoch A., Appel R.D.,
RA   Williams K.L., Hochstrasser D.F.;
RT   "Protein identification with N and C-terminal sequence tags in
RT   proteome projects.";
RL   J. Mol. Biol. 278:599-608(1998).
RN   [7]
RP   MUTAGENESIS OF HIS-108; HIS-111 AND CYS-112.
RX   PubMed=8436219; DOI=10.1016/0014-5793(93)81317-S;
RA   Berry A., Marshall K.E.;
RT   "Identification of zinc-binding ligands in the class II fructose-1,6-
RT   bisphosphate aldolase of Escherichia coli.";
RL   FEBS Lett. 318:11-16(1993).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, KINETIC
RP   PARAMETERS, REACTION MECHANISM, AND MUTAGENESIS OF ASN-36; GLN-60;
RP   SER-62 AND LYS-326.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=10712619; DOI=10.1046/j.1432-1327.2000.01191.x;
RA   Zgiby S.M., Thomson G.J., Qamar S., Berry A.;
RT   "Exploring substrate binding and discrimination in fructose 1,6-
RT   bisphosphate and tagatose 1,6-bisphosphate aldolases.";
RL   Eur. J. Biochem. 267:1858-1868(2000).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-9, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=K12 / JW1106, and K12 / MG1655 / ATCC 47076;
RX   PubMed=18723842; DOI=10.1074/mcp.M800187-MCP200;
RA   Zhang J., Sprung R., Pei J., Tan X., Kim S., Zhu H., Liu C.F.,
RA   Grishin N.V., Zhao Y.;
RT   "Lysine acetylation is a highly abundant and evolutionarily conserved
RT   modification in Escherichia coli.";
RL   Mol. Cell. Proteomics 8:215-225(2009).
RN   [10]
RP   MALONYLATION AT LYS-9.
RC   STRAIN=K12;
RX   PubMed=21908771; DOI=10.1074/mcp.M111.012658;
RA   Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,
RA   He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,
RA   Dai J., Verdin E., Ye Y., Zhao Y.;
RT   "The first identification of lysine malonylation substrates and its
RT   regulatory enzyme.";
RL   Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
RN   [11]
RP   SUCCINYLATION AT LYS-9; LYS-72; LYS-115; LYS-231; LYS-251; LYS-319;
RP   LYS-326 AND LYS-348.
RC   STRAIN=K12;
RX   PubMed=21151122; DOI=10.1038/nchembio.495;
RA   Zhang Z., Tan M., Xie Z., Dai L., Chen Y., Zhao Y.;
RT   "Identification of lysine succinylation as a new post-translational
RT   modification.";
RL   Nat. Chem. Biol. 7:58-63(2011).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.67 ANGSTROMS) IN COMPLEX WITH ZINC.
RX   PubMed=8836102; DOI=10.1038/nsb1096-856;
RA   Blom N.S., Tetreault S., Coulombe R., Sygusch J.;
RT   "Novel active site in Escherichia coli fructose 1,6-bisphosphate
RT   aldolase.";
RL   Nat. Struct. Biol. 3:856-862(1996).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH ZINC.
RX   PubMed=8939754; DOI=10.1016/S0969-2126(96)00138-4;
RA   Cooper S.J., Leonard G.A., McSweeney S.M., Thompson A.W.,
RA   Naismith J.H., Qamar S., Plater A., Berry A., Hunter W.N.;
RT   "The crystal structure of a class II fructose-1,6-bisphosphate
RT   aldolase shows a novel binuclear metal-binding active site embedded in
RT   a familiar fold.";
RL   Structure 4:1303-1315(1996).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH ZINC AND
RP   TRANSITION STATE ANALOG, AND ACTIVE SITE.
RX   PubMed=10080900; DOI=10.1006/jmbi.1999.2609;
RA   Hall D.R., Leonard G.A., Reed C.D., Watt C.I., Berry A., Hunter W.N.;
RT   "The crystal structure of Escherichia coli class II fructose-1, 6-
RT   bisphosphate aldolase in complex with phosphoglycolohydroxamate
RT   reveals details of mechanism and specificity.";
RL   J. Mol. Biol. 287:383-394(1999).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH CADMIUM, AND
RP   METAL BINDING SITES.
RX   PubMed=12595741; DOI=10.1107/S0907444902023661;
RA   Hall D.R., Kemp L.E., Leonard G.A., Marshall K., Berry A.,
RA   Hunter W.N.;
RT   "The organization of divalent cations in the active site of cadmium
RT   Escherichia coli fructose-1,6-bisphosphate aldolase.";
RL   Acta Crystallogr. D 59:611-614(2003).
CC   -!- FUNCTION: Catalyzes the aldol condensation of dihydroxyacetone
CC       phosphate (DHAP or glycerone-phosphate) with glyceraldehyde 3-
CC       phosphate (G3P) to form fructose 1,6-bisphosphate (FBP) in
CC       gluconeogenesis and the reverse reaction in glycolysis.
CC       {ECO:0000269|PubMed:10712619}.
CC   -!- CATALYTIC ACTIVITY: D-fructose 1,6-bisphosphate = glycerone
CC       phosphate + D-glyceraldehyde 3-phosphate.
CC       {ECO:0000269|PubMed:10712619}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 2 Zn(2+) ions per subunit. One is catalytic and the
CC       other provides a structural contribution.;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.17 mM for fructose-1,6-bisphosphate
CC         {ECO:0000269|PubMed:10712619};
CC         KM=0.35 mM for tagatose-1,6-bisphosphate
CC         {ECO:0000269|PubMed:10712619};
CC         Note=The catalytic efficiency measured with fructose-1,6-
CC         bisphosphate as substrate is 1440-fold higher than that with
CC         tagatose-1,6-bisphosphate.;
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-
CC       phosphate and glycerone phosphate from D-glucose: step 4/4.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10080900,
CC       ECO:0000269|PubMed:12595741, ECO:0000269|PubMed:8836102,
CC       ECO:0000269|PubMed:8939754}.
CC   -!- INTERACTION:
CC       P0A6Y8:dnaK; NbExp=2; IntAct=EBI-370916, EBI-542092;
CC   -!- SIMILARITY: Belongs to the class II fructose-bisphosphate aldolase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X14436; CAA32605.1; -; Genomic_DNA.
DR   EMBL; U28377; AAA69092.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75962.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE76989.1; -; Genomic_DNA.
DR   PIR; S02177; ADEC2A.
DR   RefSeq; NP_417400.1; NC_000913.3.
DR   RefSeq; WP_000034372.1; NZ_LN832404.1.
DR   PDB; 1B57; X-ray; 2.00 A; A/B=2-359.
DR   PDB; 1DOS; X-ray; 1.67 A; A/B=2-359.
DR   PDB; 1GYN; X-ray; 2.00 A; A=2-359.
DR   PDB; 1ZEN; X-ray; 2.50 A; A=2-359.
DR   PDBsum; 1B57; -.
DR   PDBsum; 1DOS; -.
DR   PDBsum; 1GYN; -.
DR   PDBsum; 1ZEN; -.
DR   ProteinModelPortal; P0AB71; -.
DR   SMR; P0AB71; -.
DR   BioGrid; 4262069; 17.
DR   BioGrid; 851736; 1.
DR   DIP; DIP-31872N; -.
DR   IntAct; P0AB71; 7.
DR   STRING; 511145.b2925; -.
DR   BindingDB; P0AB71; -.
DR   ChEMBL; CHEMBL4912; -.
DR   DrugBank; DB03026; Phosphoglycolohydroxamic Acid.
DR   SWISS-2DPAGE; P0AB71; -.
DR   EPD; P0AB71; -.
DR   PaxDb; P0AB71; -.
DR   PRIDE; P0AB71; -.
DR   EnsemblBacteria; AAC75962; AAC75962; b2925.
DR   EnsemblBacteria; BAE76989; BAE76989; BAE76989.
DR   GeneID; 947415; -.
DR   KEGG; ecj:JW2892; -.
DR   KEGG; eco:b2925; -.
DR   PATRIC; 32121264; VBIEscCol129921_3020.
DR   EchoBASE; EB0278; -.
DR   EcoGene; EG10282; fbaA.
DR   eggNOG; ENOG4105D2N; Bacteria.
DR   eggNOG; COG0191; LUCA.
DR   HOGENOM; HOG000227794; -.
DR   InParanoid; P0AB71; -.
DR   KO; K01624; -.
DR   OMA; RMSKMGM; -.
DR   PhylomeDB; P0AB71; -.
DR   BioCyc; EcoCyc:FRUCTBISALD-CLASSII-MONOMER; -.
DR   BioCyc; MetaCyc:FRUCTBISALD-CLASSII-MONOMER; -.
DR   BRENDA; 4.1.2.13; 2026.
DR   SABIO-RK; P0AB71; -.
DR   UniPathway; UPA00109; UER00183.
DR   EvolutionaryTrace; P0AB71; -.
DR   PRO; PR:P0AB71; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005618; C:cell wall; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0004332; F:fructose-bisphosphate aldolase activity; IDA:EcoCyc.
DR   GO; GO:0008270; F:zinc ion binding; IDA:EcoliWiki.
DR   GO; GO:0006094; P:gluconeogenesis; IBA:GO_Central.
DR   GO; GO:0006096; P:glycolytic process; IMP:EcoCyc.
DR   CDD; cd00946; FBP_aldolase_IIA; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR000771; FBA_II.
DR   InterPro; IPR006411; Fruct_bisP_bact.
DR   Pfam; PF01116; F_bP_aldolase; 1.
DR   PIRSF; PIRSF001359; F_bP_aldolase_II; 1.
DR   TIGRFAMs; TIGR00167; cbbA; 1.
DR   TIGRFAMs; TIGR01520; FruBisAldo_II_A; 1.
DR   PROSITE; PS00602; ALDOLASE_CLASS_II_1; 1.
DR   PROSITE; PS00806; ALDOLASE_CLASS_II_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Glycolysis; Lyase; Metal-binding;
KW   Reference proteome; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:2649077,
FT                                ECO:0000269|PubMed:9298646,
FT                                ECO:0000269|PubMed:9600841}.
FT   CHAIN         2    359       Fructose-bisphosphate aldolase class 2.
FT                                /FTId=PRO_0000178713.
FT   REGION      266    268       Dihydroxyacetone phosphate binding.
FT   REGION      287    290       Dihydroxyacetone phosphate binding.
FT   ACT_SITE    110    110       Proton donor.
FT                                {ECO:0000269|PubMed:10080900}.
FT   METAL       111    111       Zinc 1; catalytic.
FT                                {ECO:0000269|PubMed:10080900,
FT                                ECO:0000269|PubMed:8836102,
FT                                ECO:0000269|PubMed:8939754}.
FT   METAL       145    145       Zinc 2. {ECO:0000269|PubMed:10080900,
FT                                ECO:0000269|PubMed:8836102,
FT                                ECO:0000269|PubMed:8939754}.
FT   METAL       175    175       Zinc 2. {ECO:0000269|PubMed:10080900,
FT                                ECO:0000269|PubMed:8836102,
FT                                ECO:0000269|PubMed:8939754}.
FT   METAL       227    227       Zinc 1; catalytic.
FT                                {ECO:0000269|PubMed:10080900,
FT                                ECO:0000269|PubMed:8836102,
FT                                ECO:0000269|PubMed:8939754}.
FT   METAL       265    265       Zinc 1; catalytic.
FT                                {ECO:0000269|PubMed:10080900,
FT                                ECO:0000269|PubMed:8836102,
FT                                ECO:0000269|PubMed:8939754}.
FT   BINDING      62     62       Glyceraldehyde 3-phosphate.
FT                                {ECO:0000305}.
FT   BINDING     228    228       Dihydroxyacetone phosphate; via amide
FT                                nitrogen.
FT   MOD_RES       9      9       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:18723842}.
FT   MOD_RES       9      9       N6-malonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21908771}.
FT   MOD_RES       9      9       N6-succinyllysine; alternate.
FT                                {ECO:0000269|PubMed:21151122}.
FT   MOD_RES      72     72       N6-succinyllysine.
FT                                {ECO:0000269|PubMed:21151122}.
FT   MOD_RES     115    115       N6-succinyllysine.
FT                                {ECO:0000269|PubMed:21151122}.
FT   MOD_RES     231    231       N6-succinyllysine.
FT                                {ECO:0000269|PubMed:21151122}.
FT   MOD_RES     251    251       N6-succinyllysine.
FT                                {ECO:0000269|PubMed:21151122}.
FT   MOD_RES     319    319       N6-succinyllysine.
FT                                {ECO:0000269|PubMed:21151122}.
FT   MOD_RES     326    326       N6-succinyllysine.
FT                                {ECO:0000269|PubMed:21151122}.
FT   MOD_RES     348    348       N6-succinyllysine.
FT                                {ECO:0000269|PubMed:21151122}.
FT   MUTAGEN      36     36       N->A: 1.5% of wild-type activity. 5-fold
FT                                decrease in FBP affinity.
FT                                {ECO:0000269|PubMed:10712619}.
FT   MUTAGEN      60     60       Q->A: 81% of wild-type activity. 1.3-fold
FT                                decrease in FBP affinity.
FT                                {ECO:0000269|PubMed:10712619}.
FT   MUTAGEN      62     62       S->A: 8% of wild-type activity. 16-fold
FT                                decrease in FBP affinity.
FT                                {ECO:0000269|PubMed:10712619}.
FT   MUTAGEN      62     62       S->T: 60% of wild-type activity. 2.5-fold
FT                                decrease in FBP affinity.
FT                                {ECO:0000269|PubMed:10712619}.
FT   MUTAGEN     108    108       H->A: Loss of activity.
FT                                {ECO:0000269|PubMed:8436219}.
FT   MUTAGEN     111    111       H->A: Loss of activity.
FT                                {ECO:0000269|PubMed:8436219}.
FT   MUTAGEN     112    112       C->A: Partial loss of activity.
FT                                {ECO:0000269|PubMed:8436219}.
FT   MUTAGEN     326    326       K->A: 6% of wild-type activity. 2.2-fold
FT                                decrease in FBP affinity.
FT                                {ECO:0000269|PubMed:10712619}.
FT   HELIX         4      6       {ECO:0000244|PDB:1DOS}.
FT   STRAND       10     12       {ECO:0000244|PDB:1DOS}.
FT   HELIX        16     27       {ECO:0000244|PDB:1DOS}.
FT   STRAND       32     36       {ECO:0000244|PDB:1DOS}.
FT   HELIX        40     53       {ECO:0000244|PDB:1DOS}.
FT   STRAND       57     61       {ECO:0000244|PDB:1DOS}.
FT   HELIX        63     70       {ECO:0000244|PDB:1DOS}.
FT   HELIX        81     97       {ECO:0000244|PDB:1DOS}.
FT   HELIX        98    100       {ECO:0000244|PDB:1DOS}.
FT   STRAND      104    109       {ECO:0000244|PDB:1DOS}.
FT   HELIX       114    116       {ECO:0000244|PDB:1DOS}.
FT   HELIX       117    134       {ECO:0000244|PDB:1DOS}.
FT   STRAND      140    144       {ECO:0000244|PDB:1DOS}.
FT   HELIX       151    167       {ECO:0000244|PDB:1DOS}.
FT   STRAND      171    175       {ECO:0000244|PDB:1DOS}.
FT   HELIX       200    211       {ECO:0000244|PDB:1DOS}.
FT   STRAND      217    220       {ECO:0000244|PDB:1DOS}.
FT   HELIX       232    234       {ECO:0000244|PDB:1ZEN}.
FT   HELIX       240    253       {ECO:0000244|PDB:1DOS}.
FT   STRAND      262    264       {ECO:0000244|PDB:1DOS}.
FT   HELIX       272    280       {ECO:0000244|PDB:1DOS}.
FT   STRAND      283    288       {ECO:0000244|PDB:1DOS}.
FT   HELIX       290    307       {ECO:0000244|PDB:1DOS}.
FT   HELIX       308    310       {ECO:0000244|PDB:1DOS}.
FT   STRAND      311    317       {ECO:0000244|PDB:1DOS}.
FT   STRAND      320    324       {ECO:0000244|PDB:1DOS}.
FT   HELIX       326    329       {ECO:0000244|PDB:1DOS}.
FT   HELIX       331    352       {ECO:0000244|PDB:1DOS}.
SQ   SEQUENCE   359 AA;  39147 MW;  7A076D9EA62FBEC4 CRC64;
     MSKIFDFVKP GVITGDDVQK VFQVAKENNF ALPAVNCVGT DSINAVLETA AKVKAPVIVQ
     FSNGGASFIA GKGVKSDVPQ GAAILGAISG AHHVHQMAEH YGVPVILHTD HCAKKLLPWI
     DGLLDAGEKH FAATGKPLFS SHMIDLSEES LQENIEICSK YLERMSKIGM TLEIELGCTG
     GEEDGVDNSH MDASALYTQP EDVDYAYTEL SKISPRFTIA ASFGNVHGVY KPGNVVLTPT
     ILRDSQEYVS KKHNLPHNSL NFVFHGGSGS TAQEIKDSVS YGVVKMNIDT DTQWATWEGV
     LNYYKANEAY LQGQLGNPKG EDQPNKKYYD PRVWLRAGQT SMIARLEKAF QELNAIDVL
//
